04-25-2024, 07:40 AM
I think another aspect to consider is the evolving essence of cancer treatment. As we build more focused therapies and immunotherapies, the traditional Tnm staging system may possibly need to fit to better reflect the responsiveness of tumors to those novel treatments. Do you think the Tnm system is lithe plenty to receive such changes?